SO
CLSD

STRS Ohio’s Clearside Biomedical CLSD Stock Holding History

STRS Ohio’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-173
Closed -$20K – 1946
2017
Q1 		$20K Hold
173
– – ﹤0.01% 1831
2016
Q4 		$23K Hold
173
– – ﹤0.01% 1848
2016
Q3 		$45K Buy
+173
New +$21.2K ﹤0.01% 1777

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

STRS Ohio's CLSD Position: Q2 2017 in Review

STRS Ohio sold out of Clearside Biomedical (CLSD) in Q2 2017, closing a stake of 173 shares — an estimated $20K sold.

STRS Ohio first reported a position in CLSD in Q3 2016 and held it in 3 quarters. The position peaked at $45K in Q3 2016. 53 funds tracked by Wall St. Rank hold CLSD as of Q2 2017.

  • STRS Ohio reported no remaining Clearside Biomedical position as of Q2 2017 after selling out during the quarter.
  • STRS Ohio sold 173 Clearside Biomedical shares in Q2 2017, an estimated $20K.
  • STRS Ohio first reported a position in Clearside Biomedical in Q3 2016 and held it in 3 quarters.
  • STRS Ohio's Clearside Biomedical position peaked at $45K in Q3 2016.
  • 53 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2017.

Based on STRS Ohio's 13F filing for Q2 2017, filed 26 Jul 2017.